The neurophysiology devices and equipment market has seen considerable growth due to a variety of factors.
• There has been substantial growth in the size of the neurophysiology devices and equipment market in the past few years. The market is projected to expand from $1.61 billion in 2024 to $1.72 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%.
Factors that have contributed to this growth in the past include the increasing occurrence of neurological disorders, the heightened need for early detection, an aging population, and an increase in chronic diseases.
The neurophysiology devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for neurophysiology devices and equipment is forecasted to witness substantial growth in the coming years, expanding to a value of $2.28 billion in 2029, with a compound annual growth rate (CAGR) of 7.3%.
Various factors driving this growth outlook for the forecast period include the rise of personalized medicine, expansion in neurological research, advancements in neurorehabilitation, increased funding for neurophysiology infrastructure, and a growing demand for cloud-based neurophysiology solutions. Upcoming trends within this forecast period include technological advancements in neurophysiology, non-invasive brain stimulation methods, miniaturization and portability of equipment, functional neuroimaging, increased use of wireless and wearable devices, advances in neural interface technology, and a boost in clinical research and drug development.
The growth of the neurophysiology device and equipment market can be largely attributed to the escalating prevalence of neurological disorders globally. These disorders, ranging from brain tumors to Parkinson's disease, Alzheimer's, and others among the 600 recognized types, are among the most common recurring conditions. They lead the chart of Disability Adjusted Life Years (DALYs), representing the years lost to ill-health, disability, or premature death. As the incidence of such diseases rises along with the patient population, so does the demand for therapeutic devices. As per the UK-based Cancer Research UK charity, the average annual incidence of new brain, other CNS, and intracranial tumors in the UK is expected to surge from roughly 12,600 cases in the 2023-2025 period to approximately 13,600 cases between 2038 and 2040. Such an increase would trigger greater demand for medical devices used in neurological disorder treatment, bolstering the Neurophysiology device and equipment market over the forecast period.
The neurophysiology devices and equipment market covered in this report is segmented –
1) By Technology: Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked potential (EP)
2) By Modality: Standalone, Portable
3) By End Users: Hospitals, Ambulatory Surgical Centers
Subsegments:
1) By Electromyography (EMG): Surface EMG Devices, Needle EMG Devices, Wireless EMG Devices
2) By Electroencephalography (EEG): Conventional EEG Systems, Portable EEG Systems, Wireless EEG Systems
3) By Electrocorticography (ECoG): Grid Electrodes, Strip Electrodes, Subdural Electrodes
4) By Evoked Potential (EP): Visual Evoked Potential (VEP) Devices, Auditory Evoked Potential (AEP) Devices, Somatosensory Evoked Potential (SEP) Devices
Businesses operating in the neurophysiology devices and equipment market are channeling their investments into technological advancements to enhance the efficiency of their products. There have been numerous innovations in brain monitoring devices, including EEG monitoring, Brain Simulation therapies, and Intraoperative Neurophysiological Monitoring, for example. These latest technological breakthroughs are making feasible the production of devices that adopt or integrate procedures such as advanced neuroimaging techniques, stem cell therapies, molecular interventions, and microbiome technologies. Moreover, there's a trend toward portable and wearable device technology facilitating home-administered tracking for conditions like epilepsy and sleep apnea. To exemplify, in March 2022, Braintale, a firm based in France that develops brain medication, introduced the brainTale-care platform, aimed at white matter quantification and an offering called brainScore-com that can predict comas.
Major companies operating in the neurophysiology devices and equipment market include:
• Medtronic Plc
• Nihon Kohden Corporation
• Dr. Langer Medical Gmbh
• Natus Medical Incorporated
• Inomed Medizintechnik
• NuVasiveInc
• Axon Healthcare Ltd.
• Bovie Medical Corporation
• Neurosign
• Neurowave Systems
• Cadwell Industries
• Brainsway
• Checkpoint Surgical
• Deymed diagnostic Inc.
• EMS Biomedical
• Halyard Health
• Compumedics Limited
• Magtism
• Erbe Elektromedizi
• Langer Medical
• Shanghai NCC Medical
• Ambu
• Blackrock Microsystems
• Cognionics
• Morningside Medical Equipment
• BeckerSmith Medical
• Cognivue
• Helius Medical Technologies
• inTRAvent Medical Partners
• Neural Diagnostics Pty Ltd
• Irras AB
North America was the largest region in the neurophysiology devices and equipment market in 2024. Western Europe was the second-largest region in the global neurophysiology devices and equipment market share. The regions covered in the neurophysiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.